Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 3
1991 1
1992 3
1994 2
1995 3
1997 2
1998 3
1999 2
2000 2
2001 4
2002 2
2003 3
2004 7
2005 8
2006 5
2007 7
2008 10
2009 6
2010 8
2011 9
2012 11
2013 10
2014 12
2015 10
2016 8
2017 14
2018 5
2019 11
2020 6
2021 3
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Voriconazole pharmacogenetics.
Pallet N, Loriot MA. Pallet N, et al. Among authors: loriot ma. Lancet. 2021 Aug 14;398(10300):578. doi: 10.1016/S0140-6736(21)00879-5. Lancet. 2021. PMID: 34391494 No abstract available.
Traitements personnalisés grâce à la pharmacogénétique : niveaux de preuve et de recommandations du Réseau national de pharmacogénétique (RNPGx).
Picard N, Boyer JC, Etienne-Grimaldi MC, Barin-Le Guellec C, Thomas F, Loriot MA; Réseau national de pharmacogénétique (RNPGx). Picard N, et al. Among authors: loriot ma. Therapie. 2017 Apr;72(2):175-183. doi: 10.1016/j.therap.2016.09.007. Epub 2017 Jan 3. Therapie. 2017. PMID: 28153355 French. No abstract available.
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency.
Etienne-Grimaldi MC, Pallet N, Boige V, Ciccolini J, Chouchana L, Barin-Le Guellec C, Zaanan A, Narjoz C, Taieb J, Thomas F, Loriot MA; Francophone Network of Pharmacogenetics (RNPGx) and the French Clinical Oncopharmacology Group (GPCO)-UNICANCER. Etienne-Grimaldi MC, et al. Among authors: loriot ma. Eur J Cancer. 2023 Mar;181:3-17. doi: 10.1016/j.ejca.2022.11.028. Epub 2022 Dec 9. Eur J Cancer. 2023. PMID: 36621118 Review.
Impact of Immunosuppressive Drugs on the Metabolism of T Cells.
Pallet N, Fernández-Ramos AA, Loriot MA. Pallet N, et al. Among authors: loriot ma. Int Rev Cell Mol Biol. 2018;341:169-200. doi: 10.1016/bs.ircmb.2018.05.009. Epub 2018 Jun 19. Int Rev Cell Mol Biol. 2018. PMID: 30262032 Review.
[Pharmacogenetics for patient care in France: A discipline that evolves!].
Barin-Le Guellec C, Picard N, Alarcan H, Barreau M, Becquemont L, Quaranta S, Boyer JC, Loriot MA; réseau national de pharmacogénétique (RNPGx). Barin-Le Guellec C, et al. Among authors: loriot ma. Therapie. 2020 Sep-Oct;75(5):459-470. doi: 10.1016/j.therap.2019.09.006. Epub 2019 Oct 30. Therapie. 2020. PMID: 31767126 Review. French.
[Pharmacogenetics of anticancer drugs].
de Chaisemartin L, Loriot MA. de Chaisemartin L, et al. Among authors: loriot ma. Pathol Biol (Paris). 2005 Mar;53(2):116-24. doi: 10.1016/j.patbio.2004.05.001. Pathol Biol (Paris). 2005. PMID: 15708657 Review. French.
167 results